I name all those shareholders or their BB or Twitter names that Union Jack Oil (UJO) is using shareholder cash to troll in a most thoroughly unpleasant way as I exposed yesterday. I also comment on THG (THG), Cineworld (CINE), Tintra (TNT), Versarien (VRS) and then on the bursting of the Covid testing bubble with particular reference to Omega Diagnostics (ODX), Avacta (AVCT) and Novacyt (NCYT) which has its own BIG question to answer. Plus, of course, MyHealthChecked (MHC). I reference vaccination and covid rates in Israel in the podcast which is covered in more detail HERE.
Hello, Share Lovers. One of the best indicators of a company that might be going places is when directors have skin in the game. That is: they own a lot of shares. And it’s better still when they’ve very recently bought more. So perhaps it’s time to have another look at a AIM medical pioneer, Open Orphan (ORPH).
MyHealthChecked (MHC) has announced results for the 2020 calendar year and that “the impact of our COVID testing business is expected to have a material impact on the company’s performance in 2021”, whilst also “a strong pipeline outside of COVID-19 building, life after COVID is exciting, and we enter this phase with growing confidence in the road to delivery”. That sounds encouraging.
Hello Share Chompers. One of the more difficult sectors to call on this august website is in the covid-testing game. Of course, there are loads of aspirants to the title of being a good tester, but perhaps Avacta (AVCT) is the most covered. It certainly attracts a disproportionate number of posters on other websites, some of whom are in the hopeless optimist category…
My suggestion, made to AIM Regulation and HERE, that shares in all covid testing stocks be suspended on Monday seems to have aroused every idiot who has ever bought an AIM listed share into outrage and anger. Brokerman Dan has joined this populist outrage.